Ir a las transacciones
Salud

IMD International Medical Devices has raised funds

IMD International Medical Devices has completed an IPO on the Euronext Growth Milan market, raising a total of US$6.5 million. The funds will be used to strengthen its competitive positioning in the market and implement a growth strategy, both in Italy and abroad.

IMD International Medical Devices designs, develops, manufactures and markets diverse X-ray diagnostic systems as well as components for radiology and medical clinics.

Oaklins Italy’s parent company Banca Akros acted as the Euronext Growth advisor, global coordinator and joint bookrunner in this transaction.

Contáctese con el equipo de la transacción

Giulio Greco

Director Ejecutivo
Milán, Italia
Oaklins Italy

Giuliano Altieri

Director
Milán, Italia
Oaklins Italy

Nicola Biancoli

Asociado
Milán, Italia
Oaklins Italy

Marco Valsecchi

Asociado
Milán, Italia
Oaklins Italy

Transacciones relacionadas

MEDIK Hospital Design Group has been acquired by STERIS
Servicios de Construcción e Ingeniería | Salud

MEDIK Hospital Design Group has been acquired by STERIS

The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.

Aprenda más
Electro Optic Systems has acquired the UK interceptor business of MARSS
Aeroespacial, Defensa & Seguridad

Electro Optic Systems has acquired the UK interceptor business of MARSS

Electro Optic Systems Holdings Limited (ASX: EOS) has acquired the UK-based interceptor unmanned aerial system business of MARSS Group for US$6.4 million (€5.5 million). The interceptor is a reusable electric drone effector guided by imaging sensors and AI, which EOS will integrate into its counter-drone portfolio for defense and critical infrastructure customers. EOS plans further investment to complete development.

Aprenda más
bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Salud

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.

Aprenda más